Network origin in Jonathan Bryant first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Bryant via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DANAHER CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member | |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Founder | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
MultiPlan, Inc.
MultiPlan, Inc. Data Processing ServicesTechnology Services MultiPlan, Inc. engages in provision of healthcare cost management solutions. It offers payment integrity services, network based services, and analytic-based services. The company was founded in 1980 and is headquartered in New York, NY. | Data Processing Services | Human Resources Officer | |
ORYZON GENOMICS S.A. | Biotechnology | Director/Board Member | |
AROVELLA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Private Healthcare Systems, Inc.
Private Healthcare Systems, Inc. Medical/Nursing ServicesHealth Services Private Healthcare Systems, Inc. provides health care cost management services. The company provides its services to include self-insured employers, third-party administrators, Taft Hartley Funds, insurance companies and managed care organizations. It meets strategic, financial and quality needs of health care purchasers through care management services. The company was founded in 1985 and is headquartered in Waltham, MA. | Medical/Nursing Services | Human Resources Officer | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Masters Business Admin | |
Bentley University | College/University | Undergraduate Degree | |
Stony Brook University | College/University | Graduate Degree | |
Miami University | College/University | Undergraduate Degree Undergraduate Degree | |
Oxford Global Resources LLC
Oxford Global Resources LLC Personnel ServicesCommercial Services Oxford Global Resources LLC provides information technology, engineering, regulatory and compliance consultants. It recruits functional and technical consultants in the areas of project management and business analysis, ERP, BI, CRM, SCM, database administration, application development, information security, and IT infrastructure. The company was founded in 1984 and is headquartered in Beverly, MA. | Personnel Services | Human Resources Officer | |
Universidad Complutense de Madrid | College/University | Undergraduate Degree | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Chairman | |
Astra Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Founder | |
National Center for Biotechnology Information | General Government | Corporate Officer/Principal | |
University of Illinois College of Medicine | College/University | Doctorate Degree | |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Director/Board Member | |
CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
C4 THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
ALLOVIR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Clementia Pharmaceuticals USA, Inc.
Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Clementia Pharmaceuticals USA, Inc. is a biopharmaceutical company that aims to improve health outcomes and create a positive impact for patients and society. The company is based in Newton, MA and focuses on developing innovative medicines in oncology, neuroscience, and rare diseases. Ipsen, the parent company, regularly plans and conducts informative and transparent events for the investor community. | Pharmaceuticals: Major | President | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Point Health Tech, Inc.
Point Health Tech, Inc. Packaged SoftwareTechnology Services Point Health Tech, Inc. engages in the development of healthcare navigation platform and marketplace. The company is headquartered in Austin, TX. | Packaged Software | Director/Board Member | |
Ottawa University (Kansas) | College/University | Undergraduate Degree | |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 44 |
United Kingdom | 3 |
Spain | 3 |
Australia | 2 |
Canada | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 12 |
Commercial Services | 4 |
Finance | 3 |
Technology Services | 3 |
Operational
Director/Board Member | 72 |
Corporate Officer/Principal | 50 |
Independent Dir/Board Member | 32 |
Chairman | 23 |
Chief Executive Officer | 16 |
Most connected contacts
Insiders | |
---|---|
Georges Gemayel | 33 |
Steven Gilman | 25 |
Jose-Carlos Gutiérrez-Ramos | 24 |
Bruce Downey | 18 |
Elizabeth Stoner | 18 |
Jane Barlow | 15 |
Craig Wheeler | 12 |
Donna Grogan | 12 |
Alejandra Carvajal | 10 |
Young Kwon | 8 |
William Desmarais | 5 |
Jo-Ann Beltramello | 5 |
Ian D. Fier | 4 |
Susan Hohenleitner | 4 |
Philip Nickson | 4 |
- Stock Market
- Insiders
- Jonathan Bryant
- Company connections